2006
DOI: 10.1016/j.jchromb.2005.11.036
|View full text |Cite
|
Sign up to set email alerts
|

Sensitive quantification of omeprazole and its metabolites in human plasma by liquid chromatography–mass spectrometry

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
23
0
3

Year Published

2006
2006
2014
2014

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 42 publications
(27 citation statements)
references
References 11 publications
1
23
0
3
Order By: Relevance
“…Similarly, for the IS the m/z 370.1 precursor ion to the m/z 252.1 was used for quantification purposes. As the earlier publications (Kanazawa et al, 2002;Wang et al, 2005;Hofmann et al, 2006) have discussed extensively for the fragmentation pattern of OPZ, we are not presenting the data pertaining to this.…”
Section: Mass Spectroscopymentioning
confidence: 99%
See 1 more Smart Citation
“…Similarly, for the IS the m/z 370.1 precursor ion to the m/z 252.1 was used for quantification purposes. As the earlier publications (Kanazawa et al, 2002;Wang et al, 2005;Hofmann et al, 2006) have discussed extensively for the fragmentation pattern of OPZ, we are not presenting the data pertaining to this.…”
Section: Mass Spectroscopymentioning
confidence: 99%
“…The C max and AUC of OPZ are approximately proportional in doses up to 40 mg, but because of a saturable first-pass effect, a greater than linear response in C max and AUC occurs with doses greater than 40 mg. Absolute bioavailability (compared with intravenous administration) is about 30-40% at doses of 20-40 mg, due in large part to pre-systemic metabolism (Andersson, 1996). Several LC-MS/MS bioanalytical methods have been reported for estimation of OPZ alone or along with its metabolites in human biological samples (Woolf and Matuszewski, 1998;Stenhoff et al, 1999;Kanazawa et al, 2002;Yin et al, 2004;Frerichs et al, 2005;Wang et al, 2005;Hofmann et al, 2006;Song and Naidong, 2006;Hultman et al, 2007;Martens-Lobenhoffer et al, 2007). Although the reported LC-MS/MS methods are sensitive enough, the reported lowest limit of quantitation (LLOQ) amongst them was 0.4 ng/mL (Frerichs et al, 2005).…”
Section: Introductionmentioning
confidence: 99%
“…Lansoprazole and five metabolites were analyzed by HPLC with UV detection at 285 nm [14,17]. In addition, omeprazole and its major metabolites were determined using HPLC with UV detection at 302 nm [18][19][20][21][22] or HPLC with MS/MS [23,24]. Because the metabolites of either omeprazole or lansoprazole are inactive metabolites, their analysis is of limited importance in our pharmacokinetical context.…”
Section: Introductionmentioning
confidence: 99%
“…Moreover, few publications have reported a simple HPLC method for the simultaneous determination of OME, HOME and OMES in human plasma [15][16][17][18][19][20][21][22][23]. HPLC methods includ- ing enantioselective separation have recently become a method of choice [24][25][26][27][28].…”
Section: Introductionmentioning
confidence: 99%